- Home
- PHVS vs BELFB Comparison
PHVS vs BELFB Comparison
Compare PHVS & BELFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- BELFB
- Stock Information
- Founded
- PHVS 2015
- BELFB 1949
- Country
- PHVS Switzerland
- BELFB United States
- Employees
- PHVS N/A
- BELFB N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- BELFB
- Sector
- PHVS Health Care
- BELFB
- Exchange
- PHVS Nasdaq
- BELFB Nasdaq
- Market Cap
- PHVS 909.5M
- BELFB 865.9M
- IPO Year
- PHVS 2021
- BELFB N/A
- Fundamental
- Price
- PHVS $17.99
- BELFB $90.51
- Analyst Decision
- PHVS Buy
- BELFB Strong Buy
- Analyst Count
- PHVS 6
- BELFB 4
- Target Price
- PHVS $37.17
- BELFB $95.75
- AVG Volume (30 Days)
- PHVS 62.5K
- BELFB 140.3K
- Earning Date
- PHVS 08-13-2025
- BELFB 07-23-2025
- Dividend Yield
- PHVS N/A
- BELFB 0.31%
- EPS Growth
- PHVS N/A
- BELFB N/A
- EPS
- PHVS N/A
- BELFB 3.42
- Revenue
- PHVS N/A
- BELFB $558,940,000.00
- Revenue This Year
- PHVS N/A
- BELFB $18.21
- Revenue Next Year
- PHVS N/A
- BELFB $7.91
- P/E Ratio
- PHVS N/A
- BELFB $26.20
- Revenue Growth
- PHVS N/A
- BELFB N/A
- 52 Week Low
- PHVS $11.51
- BELFB $58.00
- 52 Week High
- PHVS $25.50
- BELFB $92.61
- Technical
- Relative Strength Index (RSI)
- PHVS 58.65
- BELFB 75.49
- Support Level
- PHVS $16.00
- BELFB $85.18
- Resistance Level
- PHVS $17.53
- BELFB $91.61
- Average True Range (ATR)
- PHVS 1.14
- BELFB 3.30
- MACD
- PHVS 0.01
- BELFB 1.35
- Stochastic Oscillator
- PHVS 59.77
- BELFB 94.70
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.